The short answer
Urothelial carcinoma, also called transitional cell carcinoma, is by far the most common type of bladder cancer. Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are much rarer and are treated differently.
Urothelial (transitional cell) carcinoma is by far the most common type of bladder cancer.
Squamous cell carcinoma makes up about 3 to 5 percent of bladder cancers.
Adenocarcinoma makes up about 1 to 2 percent of bladder cancers.
Small cell carcinoma and sarcoma are very rare bladder cancer types.
On this page
Choose how you want to read this
The whole article, with every detail and caution.
This page is for anyone who wants to understand the different types of bladder cancer. It explains the common type, the rarer types, and why the type matters for treatment.
The simple version
Most bladder cancer is one type. A small share are rarer types. These rarer types behave, and are treated, differently.
The common type
Urothelial carcinoma is also called transitional cell carcinoma. It accounts for almost all bladder cancers. It starts in urothelial cells. These cells line the inside of the bladder. They can stretch and shrink as the bladder fills and empties. That is why they are also called transitional cells. Most bladder cancer research, and most standard treatments, are built around this one type.
Rarer types
- Squamous cell carcinoma. Makes up about 3 to 5 percent of bladder cancers. It is often linked to long-term bladder irritation, such as from a chronic infection. In some parts of the world, it is linked to a parasite infection called schistosomiasis.
- Adenocarcinoma. Makes up about 1 to 2 percent of bladder cancers. It starts in gland cells, not urothelial cells. These cells normally make mucus and other fluids.
- Small cell carcinoma. Makes up less than 1 percent of bladder cancers. It starts in neuroendocrine cells, which send hormone-like signals in response to nerve activity. It tends to grow and spread quickly. It often needs chemotherapy like the kind used for small cell lung cancer.
- Sarcoma. A very rare bladder cancer. It starts in connective tissue, such as muscle.
In short, urothelial carcinoma accounts for the large majority of cases. Squamous cell carcinoma, adenocarcinoma, small cell carcinoma, and sarcoma make up the rest.
Another way doctors describe bladder cancer
Doctors also classify bladder cancer by how deep it has grown into the bladder wall. This is separate from cell type. Non-muscle-invasive bladder cancer is the more common pattern. It has not grown into the muscle layer of the bladder wall. Muscle-invasive bladder cancer has grown into or through that muscle layer. It generally needs more aggressive treatment. Your team will describe your cancer using both its cell type and this depth of invasion. Each piece carries different information.
Why type matters for treatment
Urothelial carcinoma is so common that many bladder cancer drugs were built around it. This includes many chemotherapy and immunotherapy protocols. Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma often respond differently. They may need a different combination of surgery, chemotherapy, or radiation. A standard urothelial-carcinoma protocol may not apply to them. Confirming the exact type through pathology review matters. It helps your care team choose the treatment most likely to work for your specific cancer.
What to ask your team
- What type of bladder cancer do I have?
- How confident is the pathology report in that type?
- Is my cancer muscle-invasive or non-muscle-invasive, and how does that relate to my type?
- Does my specific type change which treatments are options for me?
- How was the type confirmed, and is more testing planned?
Sources
Common questions
What is the most common type of bladder cancer?
Urothelial carcinoma, also called transitional cell carcinoma, is by far the most common type. It starts in the urothelial cells that line the inside of the bladder.
What is squamous cell carcinoma of the bladder?
This type makes up only about 3 to 5 percent of bladder cancers. It is more often linked to long-term bladder irritation or infection than urothelial carcinoma is.
Is adenocarcinoma of the bladder common?
No, it is rare, making up only about 1 to 2 percent of bladder cancers. It starts in gland cells rather than the urothelial cells that line most of the bladder.
Does the type of bladder cancer change my treatment?
Yes. Most bladder cancer treatments, including many chemotherapy and immunotherapy drugs, are developed and studied specifically for urothelial carcinoma. The rarer types often call for a different approach.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-08-05Next planned review: 2027-08-03
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.